Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02935 |
| Species: | Homo sapiens |
| Position : | chr9:37370916-37371635 |
| Year: | 2015 |
| Title: | Non-coding recurrent mutations in chronic lymphocytic leukaemia. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | B-cell chronic lymphocytic leukemia |
| PMID: | 26200345 |
| MONDO: | MONDO:0004948 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Primary CLL cells |
| Cell Type: | B cell |
| Cell Ontology ID: | CL:0000236 |
| Experiment Type: | Regulatory variant assay; Chromatin interaction assay; Functional enhancer perturbation |
| High Throughput Method: | WGS; RNA-seq; epigenomic profiling; 4C-seq |
| Low Throughput Method: | CRISPR/Cas9 enhancer mutation/deletion; PAX5 expression analysis; targeted validation |
| Target gene : | PAX5 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|